176 related articles for article (PubMed ID: 22665139)
1. Identification of germline genomic copy number variation in familial pancreatic cancer.
Al-Sukhni W; Joe S; Lionel AC; Zwingerman N; Zogopoulos G; Marshall CR; Borgida A; Holter S; Gropper A; Moore S; Bondy M; Klein AP; Petersen GM; Rabe KG; Schwartz AG; Syngal S; Scherer SW; Gallinger S
Hum Genet; 2012 Sep; 131(9):1481-94. PubMed ID: 22665139
[TBL] [Abstract][Full Text] [Related]
2. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?
Fanale D; Iovanna JL; Calvo EL; Berthezene P; Belleau P; Dagorn JC; Bronte G; Cicero G; Bazan V; Rolfo C; Santini D; Russo A
Expert Opin Ther Targets; 2014 Aug; 18(8):841-50. PubMed ID: 24834797
[TBL] [Abstract][Full Text] [Related]
3. Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations.
Fanale D; Iovanna JL; Calvo EL; Berthezene P; Belleau P; Dagorn JC; Ancona C; Catania G; D'Alia P; Galvano A; Gulotta E; Lo Dico S; Passiglia F; Bronte G; Midiri M; Lo Re G; Cicero G; Bazan V; Russo A
Oncology; 2013; 85(5):306-11. PubMed ID: 24217364
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A germline mutations in familial pancreatic cancer.
Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
[TBL] [Abstract][Full Text] [Related]
5. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.
Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P
Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
[TBL] [Abstract][Full Text] [Related]
7. Copy number variants and VNTR length polymorphisms of the carboxyl-ester lipase (CEL) gene as risk factors in pancreatic cancer.
Dalva M; El Jellas K; Steine SJ; Johansson BB; Ringdal M; Torsvik J; Immervoll H; Hoem D; Laemmerhirt F; Simon P; Lerch MM; Johansson S; Njølstad PR; Weiss FU; Fjeld K; Molven A
Pancreatology; 2017; 17(1):83-88. PubMed ID: 27773618
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition in degenerative lumbar scoliosis due to the copy number variation.
Shin JH; Ha KY; Jung SH; Chung YJ
Spine (Phila Pa 1976); 2011 Oct; 36(21):1782-93. PubMed ID: 21587107
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
[TBL] [Abstract][Full Text] [Related]
10. Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility.
Oketch DJA; Giulietti M; Piva F
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203561
[TBL] [Abstract][Full Text] [Related]
11. Germline DNA copy number variation in familial and early-onset breast cancer.
Krepischi AC; Achatz MI; Santos EM; Costa SS; Lisboa BC; Brentani H; Santos TM; Gonçalves A; Nóbrega AF; Pearson PL; Vianna-Morgante AM; Carraro DM; Brentani RR; Rosenberg C
Breast Cancer Res; 2012 Feb; 14(1):R24. PubMed ID: 22314128
[TBL] [Abstract][Full Text] [Related]
12. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.
Wong C; Chen F; Alirezaie N; Wang Y; Cuggia A; Borgida A; Holter S; Lenko T; Domecq C; ; Petersen GM; Syngal S; Brand R; Rustgi AK; Cote ML; Stoffel E; Olson SH; Roberts NJ; Akbari MR; Majewski J; Klein AP; Greenwood CMT; Gallinger S; Zogopoulos G
PLoS Genet; 2019 Aug; 15(8):e1008344. PubMed ID: 31469826
[TBL] [Abstract][Full Text] [Related]
13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
14. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
15. Copy-number variants in patients with a strong family history of pancreatic cancer.
Lucito R; Suresh S; Walter K; Pandey A; Lakshmi B; Krasnitz A; Sebat J; Wigler M; Klein AP; Brune K; Palmisano E; Maitra A; Goggins M; Hruban RH
Cancer Biol Ther; 2007 Oct; 6(10):1592-9. PubMed ID: 17912030
[TBL] [Abstract][Full Text] [Related]
16. Germline copy number variations are associated with breast cancer risk and prognosis.
Kumaran M; Cass CE; Graham K; Mackey JR; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2017 Nov; 7(1):14621. PubMed ID: 29116104
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk.
Willis JA; Mukherjee S; Orlow I; Viale A; Offit K; Kurtz RC; Olson SH; Klein RJ
Front Genet; 2014; 5():29. PubMed ID: 24592275
[TBL] [Abstract][Full Text] [Related]
18. A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility.
Sapkota Y; Narasimhan A; Kumaran M; Sehrawat BS; Damaraju S
Cytogenet Genome Res; 2016; 149(3):156-164. PubMed ID: 27668787
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
[TBL] [Abstract][Full Text] [Related]
20. Bayesian copy number detection and association in large-scale studies.
Cristiano S; McKean D; Carey J; Bracci P; Brennan P; Chou M; Du M; Gallinger S; Goggins MG; Hassan MM; Hung RJ; Kurtz RC; Li D; Lu L; Neale R; Olson S; Petersen G; Rabe KG; Fu J; Risch H; Rosner GL; Ruczinski I; Klein AP; Scharpf RB
BMC Cancer; 2020 Sep; 20(1):856. PubMed ID: 32894098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
